摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-氯异喹啉-3-羧酸甲酯 | 349552-70-1

中文名称
1-氯异喹啉-3-羧酸甲酯
中文别名
1-氯异喹啉-3-甲酸甲酯
英文名称
methyl 1-chloroisoquinoline-3-carboxylate
英文别名
1-chloro-isoquinoline-3-carboxylic acid methyl ester
1-氯异喹啉-3-羧酸甲酯化学式
CAS
349552-70-1
化学式
C11H8ClNO2
mdl
MFCD09863391
分子量
221.643
InChiKey
KJBHVFGDDKSFGN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    39.2
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Structure activity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan (NAQ) analogues as potent opioid receptor ligands: Preliminary results on the role of electronic characteristics for affinity and function
    摘要:
    17-Cyclopropylmethyl-3,14 beta-dihydroxy-4,5 alpha-epoxy-6 alpha-(isoquinoline-3'-carboxamido)morphinan (NAQ) was previously designed following the 'message-address' concept and was identified as a potent and highly selective mu opioid receptor (MOR) ligand based on its pharmacological profile. We here report the preliminary structure activity relationship (SAR) studies of this novel lead compound. For the new ligands synthesized as NAQ analogues, their binding assay results showed that a longer spacer and a saturated ring system of the side chain were unfavorable for their MOR selectivity over the kappa and delta opioid receptors. In contrast, substitutions with different electronic properties at either 1'- or 4'-position of the isoquinoline ring of the side chain were generally acceptable for reasonable MOR selectivity. The majority of NAQanalogues retained low efficacy at the MOR compared to NAQin the S-35-GTP[gamma S] binding assays while electron-withdrawing groups at 1'-position of the isoquinoline ring induced higher MOR stimulation than electron-donating groups did. In summary, the electronic characteristics of substituents at 1'- or 4'-position of the isoquinoline ring in NAQ seem to be critical and need to be further tuned up to achieve higher MOR selectivity and lower MOR stimulation. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2013.07.043
  • 作为产物:
    描述:
    1-氧代-1,2,3,4-四氢异喹啉-3-甲酸 在 10percent Pd/C 硫酸potassium carbonate三氯氧磷 作用下, 以 二苯醚乙腈 为溶剂, 反应 9.5h, 生成 1-氯异喹啉-3-羧酸甲酯
    参考文献:
    名称:
    Synthetic approaches to 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid
    摘要:
    为了研究新的抗肿瘤化合物,我们在此报告了以前未曾描述过的 1-(2-氯苯基)异喹啉-3-羧酸 9 的制备方法。我们研究了从苯乙胺或安非他明出发的两种相关方法,发现都很成功。此外,还利用 2-氯苯硼酸 15 与之前未报道过的 1-溴异喹啉-3-羧酸甲酯 14 之间的铃木交叉偶联,开发出了一种更可靠的合成方法。这一合成路线为采用组合方法研究新的潜在外周苯并二氮杂卓受体配体的核心结构奠定了基础。
    DOI:
    10.1039/b110301f
点击查看最新优质反应信息

文献信息

  • Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists
    作者:Raimo Saari、Jonna-Carita Törmä、Tapio Nevalainen
    DOI:10.1016/j.bmc.2010.11.059
    日期:2011.1
    Quinoline, isoquinoline, quinoxaline, and quinazoline derivatives were synthesized using microwave-assisted synthesis and their CB1/CB2 receptor activities were determined using the [35S]GTPγS binding assay. Most of the prepared quinoline, isoquinoline, and quinoxalinyl phenyl amines showed low-potency partial CB2 receptor agonists activity. The most potent CB2 ligand was the 4-morpholinylmethanone
    使用微波辅助合成法合成喹啉,异喹啉,喹喔啉和喹唑啉衍生物,并使用[ 35 S]GTPγS结合测定法测定其CB1 / CB2受体活性。大部分制备的喹啉,异喹啉和喹喔啉基苯胺均显示出低效的部分CB2受体激动剂活性。最有效的CB2配体是4-吗啉基甲酮衍生物(化合物40e)(-log EC 50  = 7.8;E max  = 75%)。异喹啉-1-基(3-三氟甲基-苯基)胺(化合物26c)是一种高效的CB2激动剂(-log EC 50  = 5.8; E max = 128%)。在这些研究中,没有发现明显的CB1受体激活或失活,除了40e表现出弱的CB1激动剂活性(CB1-log EC 50  = 5.0)。这些配体用作开发选择性CB2受体激动剂的新型模板。
  • [EN] PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS<br/>[FR] DÉRIVÉS DE PIPÉRAZINE ET LEUR UTILISATION À TITRE DE MODULATEURS ALLOSTÉRIQUES POSITIFS DES RÉCEPTEURS MGLUR5
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2013087805A1
    公开(公告)日:2013-06-20
    This invention relates to compounds of formula (I) their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. R1, R2, R3, R4, Q have meanings given in the description.
    这项发明涉及公式(I)化合物,它们作为mGlu5受体活性的正向变构调节剂的用途,含有这些化合物的药物组合物,以及将其用作治疗和/或预防与谷氨酸功能障碍相关的神经和精神障碍,如精神分裂症或认知功能下降,如痴呆症或认知障碍的药剂的方法。R1、R2、R3、R4、Q在描述中有给定的含义。
  • NOVEL COMPOUNDS
    申请人:HEIMANN Annekatrin
    公开号:US20130158042A1
    公开(公告)日:2013-06-20
    This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. R 1 , R 2 , R 3 , R 4 , Q have meanings given in the description.
    这项发明涉及公式I的化合物,它们作为mGlu5受体活性的正向变构调节剂的用途,含有这些化合物的药物组合物,以及将其用作治疗和/或预防与谷氨酸功能障碍相关的神经和精神障碍,如精神分裂症或认知功能下降,如痴呆症或认知障碍的药剂的方法。R1,R2,R3,R4,Q在描述中给出了含义。
  • [EN] COMPOUNDS FOR INDUCING CELLULAR APOPTOSIS<br/>[FR] COMPOSÉS ENTRAÎNANT L'APOPTOSE
    申请人:QUEEN MARY & WESTFIELD COLLEGE
    公开号:WO2010125343A1
    公开(公告)日:2010-11-04
    The present invention provides isoquinoline, tetrahydroisoquinoline and tetrahydropyridopyrimidine compounds that induce cell death by apoptosis and uses of the compounds in medicine, expecially their use for treating cancer and other diseases.
    本发明提供了诱导细胞凋亡的异喹啉、四氢异喹啉和四氢吡啶吡咯啉化合物,以及这些化合物在医学上的用途,尤其是它们用于治疗癌症和其他疾病的用途。
  • Resolution and coupling of 1-(2′-hydroxy-1′-naphthyl)isoquinolines
    作者:Sonia C Tucker、John M Brown、John Oakes、David Thornthwaite
    DOI:10.1016/s0040-4020(01)00064-3
    日期:2001.3
    The synthesis of bridged dimeric isoquinolylnaphthols has been developed. A simple method for the resolution of 1,1′-isoquinolyl-2′-naphthol permits measurement of the optical stability of the monomer, and in several cases slow racemisation at ambient temperature was observed. The enantiomeric stability is not greatly affected by steric buttressing. An unusual enhancement of the rate of atropisomerism
    已经开发了桥联的二聚异喹啉基萘酚的合成。一种简单的拆分1,1'-异喹啉基-2'-萘酚的方法可以测量单体的光学稳定性,并且在某些情况下,在环境温度下观察到缓慢的外消旋作用。对映体稳定性不受空间支撑的影响很大。3-溴甲基异喹啉可显着提高阻转异构率,并消除了偶联纯对映体组分以提供四齿配体的单一立体异构体的可能性。
查看更多